Texas A&M University Health Science Center: Heart Failure After Chemotherapy - New Insights Light the Way for Possible Therapeutic
June 24, 2023
June 24, 2023
COLLEGE STATION, Texas, June 24 (TNSjou) -- Texas A&M University's Health Science Center issued the following news:
* * *
Recent research finds the immune sensor Z-DNA binding protein 1 (ZBP1) may be a novel therapeutic target in chemotherapy-related cardiac dysfunction
* * *
If you or a loved one has ever been treated for cancer with chemotherapy, you are likely aware of the common side effects of these widely used treatments, including fa . . .
* * *
Recent research finds the immune sensor Z-DNA binding protein 1 (ZBP1) may be a novel therapeutic target in chemotherapy-related cardiac dysfunction
* * *
If you or a loved one has ever been treated for cancer with chemotherapy, you are likely aware of the common side effects of these widely used treatments, including fa . . .